Search
Close this search box.

Vomaris Patent Estate Expands

VOMARIS PATENT ESTATE GROWS TO SIX ISSUED U.S. PATENTS AND THREE GRANTED INTERNATIONAL PATENTS WITH U.S. PAT. NO. 8,224,439 Vomaris Innovations, Inc, a leading regenerative medicine company...

Read More »

Vomaris Innovations, Inc. Names New CEO

Vomaris Innovations, Inc, a leading regenerative medicine company focusing on wound care with bioelectric technology, has named Michael P. Nagel as its new President and Chief Executive Officer. Mr....

Read More »

K-128 Rev. A – Last updated: May 2024

Thank you for contacting Vomaris.
We will respond to you within 48 hours.

Skip to content